ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 57 filers reported holding ALPINE IMMUNE SCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $154,781 | +77.4% | 13,518 | +59.2% | 0.00% | – |
| Q2 2023 | $87,267 | -44.9% | 8,489 | -58.6% | 0.00% | – |
| Q1 2023 | $158,399 | +38.9% | 20,518 | +32.3% | 0.00% | – |
| Q4 2022 | $114,006 | -99.8% | 15,511 | +136.0% | 0.00% | – |
| Q3 2022 | $47,318,000 | +59.7% | 6,572 | +88.7% | 0.00% | – |
| Q2 2022 | $29,632,000 | -12.5% | 3,482 | -7.8% | 0.00% | – |
| Q1 2022 | $33,880,000 | -24.6% | 3,777 | +16.4% | 0.00% | – |
| Q4 2021 | $44,957,000 | +99.1% | 3,246 | +53.4% | 0.00% | – |
| Q3 2021 | $22,578,000 | +460.0% | 2,116 | +372.3% | 0.00% | – |
| Q2 2021 | $4,032,000 | – | 448 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 2,571,450 | $17,640,000 | 4.25% |
| BVF INC/IL | 1,201,717 | $8,244,000 | 0.92% |
| Orbimed Advisors | 3,670,955 | $25,183,000 | 0.39% |
| TIGER MANAGEMENT L.L.C. | 137,728 | $945,000 | 0.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 475,450 | $3,262,000 | 0.12% |
| Hikari Power Ltd | 122,972 | $844,000 | 0.09% |
| ALPINE WOODS CAPITAL INVESTORS, LLC | 15,000 | $103,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 35,750 | $245,000 | 0.00% |
| DRW Securities, LLC | 10,000 | $69,000 | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 134,542 | $923,000 | 0.00% |